Merck recognizes that new methods and a broader scope of partnering – with both public and private entities – are critical to continuing innovation. This is true for all diseases, and especially true for neglected diseases, in which the relevant expertise spans academia, a diverse set of local public health authorities, industry and international agencies. We plan to continue and to expand our interaction with these groups to understand key research priorities and opportunities, and to support those with relevant expertise and resources where possible.

The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.